Aurobindo Pharma shares fall 1.38 per cent in Thursday’s trading session

The scrip had closed at Rs 690.55 in the previous session. The stock quoted a 52-week low of Rs 590.25 and a high of Rs 1063.75. The company quoted a market-cap of Rs 39902.42 crore on the BSE.

On BSE, 52,719 shares have changed hands on the counter so far. At its prevailing price, the stock traded at 13.89 times its trailing 12-month EPS of Rs 49.04 per share and 2.36 times its book value. The return on equity (ROE) stood at Rs 24.32.

Key Financials

For the quarter ended 31-Dec-2021, Aurobindo Pharma Ltd. reported consolidated sales of Rs 6067.21 crore, up 6.63 per cent from the same quarter a year ago. The company reported 79.48 per cent YoY de-growth in net profit at Rs 604.73 crore for the latest quarter.

Technical indicators

The relative strength index (RSI) of the stock stood at Thursday. The RSI oscillates between zero and 100. Traditionally, it is considered overbought condition when the RSI value is above 70 and oversold when it is below 30.

Analysts say the RSI indicator should not be seen in isolation, as it may not be sufficient to take a trading call, just the way a fundamental analyst cannot give a “buy” or “sell” recommendation using a single valuation ratio.